Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
companies
ONYX Pharmaceuticals
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Afinitor
Avastin
Aveo Oncology
Bayer
BMS-936558
Bristol-Myers Squibb
GSK
Inlyta
kidney cancer
Nexavar
Novartis
ONYX Pharmaceuticals
Pfizer
Roche
Sutent
tivozanib
Votrient
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Amarin
Astellas
Bayer
Cardinal Health
Celsion
Hyperion Therapeutics
JNJ
Medivation
Navidea Biopharmaceuticals
Novartis
ONYX Pharmaceuticals
Peregrine Pharmaceuticals
Pharmacyclics
Prana
Sangamo BioSciences
Sarepta
Trius
Vertex Pharmaceuticals
Onyx Pharmaceuticals Inc.: Today's Featured Health Care Laggard
Onyx Pharmaceuticals Inc.: Today's Featured Health Care Laggard
The Street
ONYX Pharmaceuticals
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
Motley Fool
AstraZeneca
Bayer
Caprelsa
Cometriq
Exelixis
Nexavar
ONYX Pharmaceuticals
thyroid cancer
Celgene's Rich Pipeline Offers Growth
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Abraxane
Bristol-Myers Squibb
Celgene
Eli Lilly
ONYX Pharmaceuticals
Pomalyst
Revlimid
Roche
The Oncology Stock to Buy Today
The Oncology Stock to Buy Today
Motley Fool
ONYX Pharmaceuticals
Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
Onyx Pharmaceuticals CEO: Seeking Acquisition Targets
Fox Business News
M&A
ONYX Pharmaceuticals
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Arimidex
aromatase inhibitors
AstraZeneca
breast cancer
Femara
GSK
Herceptin
Immunogen
Kadcyla
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
Nolvadex
Novartis
ONYX Pharmaceuticals
Perjeta
Roche
SERMs
Tykerb
Xeloda
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Bristol-Myers Squibb
Celgene
immunotherapy
OncoSec
ONYX Pharmaceuticals
Vical
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
AbbVie
Bristol-Myers Squibb
Celgene
JNJ
Multiple Myeloma
ONYX Pharmaceuticals
Revlimid
Velcade
1
2
3
4
5
6
7
8
9
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT